PEAK BIO INC

BOSTON and PLEASANTON, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX, “Akari”) and Peak Bio Inc. (OTC: PKBO, “Peak”) today announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC (antibody drug conjugate) platform technology and Akari’s PAS-nomacopan Geographic Atrophy (GA) program. Peak’s ADC platform technology is a proprietary technology using antibody plus linker plus Peak Bio toxin with immune modulation and includes a novel pre-clinical ADC candidate targeting TROP-2. Akari’s PAS-nomacopan is a bispecific complement and leukotriene B4 inhibitor with prolonged duration of action being developed for GA.

Related tickers: PKBO.

Gainers Sotera Health Company (NASDAQ: SHC) shares jumped 92% to $16.59 after the company announced its subsidiaries have reached agreements to settle the Ethylene Oxide cases pending against Sterigenics. Sterigenics will pay the company $408 million to settle the claims. Party City Holdco Inc. (NYSE: PRTY) gained 54% to $0.3193 following an Axios report suggesting The Franchise Group could be looking at acquiring the company. Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares rose 51.1% to $0.1224 after gaining 4% on Monday. VYNE Therapeutics Inc. (NASDAQ: VYNE) climbed 50.5% to $0.2892 after the company announced the first vitiligo patient was dosed in a Phase 1a/b clinical trial of VYN201. Elys Game Technology, Corp. (NASDAQ: ELYS) jumped 49.5% to $0.6276. Boxed, Inc. (NYSE: BOXD) gained 36.6% to $0.5191 after the company announced its Spresso Saas modular solution platform is now available on Google Cloud. Biora Therapeutics, Inc. (NASDAQ: BIOR) rose 35% to $2.85. HC Wainwright & Co. maintained Biora Therapeutics with a Buy. DermTech, Inc. (NASDAQ: DMTK) shares climbed 32.6% to $2.88 after DermTech announced the foundational assay of its DermTech Melanoma Test (DMT) is recommended for coverage by TRICARE. DatChat, Inc. (NASDAQ: DATS) gained 31.7% to $0.48 after the company announced a $2 million stock repurchase plan. POET Technologies Inc. (NASDAQ: POET) gained 31.3% to $4.2750. Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) gained 30% to $1.5657. Rubius Therapeutics, Inc. (NASDAQ: RUBY) jumped 29.4% to $0.2349. Oak Street Health, Inc. (NYSE: OSH) gained 28.4% to $28.99 as CVS Health is reportedly exploring an acquisition of primary care center operator. BTCS Inc. (NASDAQ: BTCS) jumped 28.2% to $1.3199 after the company launched a private beta of its digital asset analytic and staking-as-a-service platform StakeSeeker. Frontline plc (NYSE: FRO) rose 27.1% to $14.40. Frontline announced termination of combination agreement with Euronav. Schmitt Industries, Inc. (NASDAQ:

Related tickers: FREQ, DATS, BIOR, ACCD, ARBK, BOX, BLI, AMRN, VORB, BTCS, ALXO, BBBY, POET, DMTK, CVAC, HSKA, APGN, PRTY, VYNE, IDRA, JZ, RYAM, ELYS, SMCI, SATX, CALA, PBLA, SMIT, PKBO, EURN, VCEL, BCAB, FRO, RAIN, MTP, VS, LHDX, PRE, ISO, NPCE, LODE, RUBY, OTLY, OSH, TMDI, BHG, BIOL, GMVD, AMAM, SHC, KRUS, BOXD, SMMT.